Katie M Leick

41PUBLICATIONS
98CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyMolecular targetsInnate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Apr 10, 2026
Randomized Phase I/II Clinical Trial of a Melanoma Helper Peptide Vaccine with or without Systemic Agonistic Anti-CD27 Antibody (Varlilumab).

Emily K Ninmer, Gina R Petroni, Elizabeth Gaughan

|Mar 18, 2026
Impact of GM-CSF and Two-Site Vaccination on Clinical Outcomes after Multipeptide Vaccination for Melanoma: Long-term Analysis of a Randomized Phase II Trial.

Emily K Ninmer, Hong Zhu, Amrita Sarkar

|Mar 03, 2026
Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC).

Emily K Ninmer, Gina R Petroni, Brian R Gastman

|Feb 26, 2026
Evaluation of Antibodies Induced by Melanoma Helper Peptide Vaccine and Their Modulation by Vaccine Adjuvants.

Emily G Ashkani, Anna M Dickinson, Walter C Olson

|Feb 26, 2025
Sex and Age-Based Differences in Immune Responses to a Peptide Vaccine for Melanoma in Two Clinical Trials.

Serena M Vilasi, Craig L Slingluff

|Sep 19, 2024
Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer.

Remziye E Wessel, Nardin Ageeb, Joseph M Obeid

Pageof 7

Frequent Collaborators

5 joint publications

Timothy N J Bullock

4 joint publications

Kimberly A Chianese-Bullock

3 joint publications

Ileana S Mauldin

3 joint publications

Emily K Ninmer